NCT06428825 - A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

November 21, 2025

Study Completion Date

November 21, 2025

Conditions

Chronic Kidney DiseaseArterial Hypertension

Interventions

DRUG

BAY3283142

oral administration

DRUG

Placebo to BAY3283142

oral administration

Trial Locations (2)

RECRUITING

CRS Clinical Research Services Berlin GmbH, Berlin

RECRUITING

"Clinical Research Services , Clinical Research Services Mannheim - Phase one unit"